期刊全名
PROSTATE CANCER AND PROSTATIC DISEASES
最新影响因子
5.1年均收录文章
64期刊简称
PROSTATE CANCER P D来源地区
ENGLAND详细类别
UROLOGY & NEPHROLOGY泌尿学与肾脏学
2区
ONCOLOGY肿瘤学
3区
中科院杂志分区
医学(2区)是否OA开放访问
No投稿难度
较易出版周期
Quarterly投稿链接
点击投稿杂志主页
点击查看杂志主页自引率
3.60%类别
医学-泌尿学与肾脏学coverage
Science Citation Index Expanded审稿周期
较慢,6-12周《Prostate Cancer and Prostatic Diseases》是一本专注于前列腺癌和前列腺疾病的国际学术期刊，ISSN号为1365-7852，由Springer Nature出版，出版地为英国，出版周期为季刊。该期刊被SCI收录，2022年影响因子为4.8，属于中科院医学大类三区，非开放获取（OA）期刊。其发文特点集中于前列腺癌的基础与临床研究，涵盖流行病学、分子机制、诊断技术、治疗策略及患者生活质量等领域，尤其关注多学科交叉研究和转化医学应用。杂志质量较高，审稿严格，但作为专科期刊，读者群体相对局限，且近年竞争加剧可能导致投稿难度上升，需注意研究创新性与临床相关性以提升录用率。
Ultra-hypofractionation for node-positive prostate cancer: pushing boundaries and redefining standards
2025-05-08T19:54:49Z
Integrating clinical and technological perspectives to enhance predictive modeling in prostate cancer surgery
2025-05-06T13:26:05Z
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial
2025-05-03T15:07:07Z
Gleason pattern 4 and active surveillance in patients with grade group 2 prostate cancer
2025-04-29T11:48:03Z
Short term results after minimally invasive treatments for benign prostatic enlargement: the first randomized trial comparing transperineal laser ablation and water vapor ablation
2025-04-25T12:09:58Z
Endoscopic enucleation of the prostate (EEP) versus transurethral resection of the prostate (TURP): advantages and implications
2025-04-23T06:18:39Z
Endoscopic enucleation vs. robot-assisted simple prostatectomy for large prostates: a systematic review and meta-analysis of patients’ perspectives
2025-04-18T06:13:06Z
Real-world analyses of major adverse cardiovascular events and mortality risk after androgen deprivation therapy initiation in black vs. white prostate cancer patients
2025-04-18T09:31:21Z
Rezūm water vapor therapy vs. thulium laser enucleation for the treatment of benign prostatic hyperplasia in patients with large prostates: a multicenter prospective comparative study
2025-04-14T14:59:51Z
New trends on the management of localized prostate cancer
2025-04-08T12:54:32Z
The association between statin use, genetic variation, and prostate cancer risk
2025-04-07T19:47:00Z
Real-world utilization patterns and survival in men with metastatic prostate cancer treated with Radium-223 in the United States
2025-04-05T03:25:30Z
Racial variation in the advanced prostate cancer genome
2025-04-10T11:39:50Z
Concerns regarding the methodological limitations of the OASIS study
2025-03-29T04:51:00Z
Does biodegradable peri-rectal spacer mitigate treatment toxicities in radiation therapy for localised prostate cancer—a systematic review and meta-analysis
2025-03-28T05:22:40Z
New kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy – a comprehensive review
2025-03-27T02:28:24Z
Enzalutamide in patients with high-risk biochemically recurrent prostate cancer according to the European Association of Urology definition: a post hoc analysis of EMBARK
2025-03-26T05:55:07Z
From association to action: strengthening research on social determinants of health
2025-03-25T18:41:19Z
Whack-a-met: serial SABR for repeated oligoprogression in metastatic CRPC
2025-03-24T03:59:46Z
